Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies

Bioconjugate Chemistry

Volumn 14, Issue 3, 2003, Pages 563-574

  Aronov, Olga ^a   Horowitz, Aviva T ^b   Gabizon, Alberto ^b   Gibson, Dan ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; CYTOLOGY; DNA; MOLECULAR BIOLOGY;

BLOOD CIRCULATION; CARBOPLATIN; CELLULAR UPTAKE; DNA-BINDING; FOLATES; IN-VITRO; LOW MOLECULAR WEIGHT DRUGS; NON-TARGETED; RECEPTOR-MEDIATED ENDOCYTOSIS; VITRO STUDIES;

PLATINUM;

CARBOPLATIN; DNA; DRUG CARRIER; FOLIC ACID; MACROGOL;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CYTOTOXICITY; DNA ADDUCT; DNA BINDING; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENDOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; IC 50; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0038246506     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025642l     Document Type: Article

References (33)

1. Calvert, A. H., Harland, S. J., Newell, D. R., Siddik, Z. H., Jones, A. C., McElwain, T. J., Raju, S., Wiltshaw, E., Smith, I. E., Baker, J. M., Peckham, M. J., and Harrap, K. R. (1982) Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother. Pharmacol. 9, 140-147.
2. Curt, G. A., Grygiel, J. J., Corden, B. J., Ozols, R. F., Weiss, R. B., Tell, D. T., Myers, C. E., and Collins, J. M. (1983) A phase I and pharmacokinetic study of diamminecyclobutanedicarboxylatoplatinum (NSC 241240). Cancer Res. 43, 4470-4473.
3. Wiltshaw, E. (1985) Ovarian trials at the Royal Marsden. Cancer Treat. Rev. 12 Suppl A, 67-71.
4. Micetich, K. C., Barnes, D., and Erickson, L. C. (1985) A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells. Cancer Res. 45, 4043-4047.
5. Knox, R. J., Friedlos, F., Lydall, D. A., and Roberts, J. J. (1986) Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res. 46, 1972-1979.
6. Frey, U., Ranford, J. D., and Sadler, P. J. (1993) Ring-Opening Reactions of the Anticancer Drug Carboplatin NMR Characterization of Cis-[Pt(Nh3)2(Cbdca-O)(5′-GmpN7)] in Solution. Inorg. Chem. 32, 1333-1340.
7. Blommaert, F. A., van Dijk-Knijnenburg, H. C., Dijt, F. J., den Engelse, L., Baan, R. A., Berends, F., and FichtingerSchepman, A. M. (1995) Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34, 8474-8480.
8. Lokich, J., and Anderson, N. (1998) Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann. Oncol. 9, 13-21.
9. Sancho, A. R., and Dowell, J. A.; Wolf, W. (1997) The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study. Cancer Chemother. Pharmacol. 40, 521-525.
10. Takakura, Y., and Hashida, M. (1996) Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution. Pharm. Res. 13, 820-831.
11. Zalipsky, S. (1995) Chemistry of Polyethylene-Glycol Conjugates with Biologically-Active Molecules. Adv. Drug Delivery Rev. 16, 157-182.
12. Sehon, A. H. (1991) Suppression of Antibody-Responses by Conjugates of Antigens and Monomethoxypoly(Ethylene Glycol). Adv. Drug Delivery Rev. 6, 203-217.
13. Delgado, C., Francis, G. E., and Fisher, D. (1992) The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Carrier Syst. 9, 249-304.
14. Zalipsky, S., Brandeis, E., Newman, M. S., and Woodle, M. C. (1994) Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett. 353, 71-74.
15. Ohya, Y. S., S., Matsumoto, M., and Ouchi, T. (2000) Design of poly(ethylene glycol) immobilizing platinum complex through chelate-type coordination bond. Polym. Adv. Technol. 11, 635-641.
16. Duncan, R., Connors, T. A., and Meada, H. (1996) Drug targeting in cancer therapy: the magic bullet, what next? J. Drug Target. 3, 317-319.
17. Wang, S., and Low, P. S. (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Controlled Release 53, 39-48.
18. Sudimack, J., and Lee, R. J. (2000) Targeted drug delivery via the folate receptor. Adv. Drug Delivery Rev. 41, 147-162.
19. Elwood, P. C. (1989) Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem. 264, 14893-14901.
20. McHugh, M., and Cheng, Y. C. (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J. Biol. Chem. 254, 11312-11318.
21. Anderson, R. G., Kamen, B. A., Rothberg, K. G., and Lacey, S. W. (1992) Potocytosis: sequestration and transport of small molecules by caveolae. Science 255, 410-411.
22. Rothberg, K. G., Ying, Y. S., Kolhouse, J. F.; Kamen, B. A.; Anderson, R. G. (1990) The glycophospholipid-linked folate receptor internalizes folate without entering the clathrincoated pit endocytic pathway. J. Cell Biol. 110, 637-649.
23. Mantovani, L. T., Miotti, S., Menard, S., Canevari, S., Raspagliesi, F., Bottini, C., Bottero, F., and Colnaghi, M. I. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19. (1994) Eur. J. Cancer 30A, 363-369.
24. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., Jr., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
25. Kay, L. E., Keifer, P. A., and Saarinen, T. (1992) Pure Absorption Gradient Enhanced Heteronuclear Single Quantum Correlation Spectroscopy with Improved Sensitivity. J. Am. Chem. Soc. 114, 10663-10665.
26. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem. 10, 289-298.
27. 15N N. M. R. (1981) Study of the Anticancer Drug, cis-Diamminedichloroplatinum(II), and its Hydrolysis and Oligomerization Products. Aust. J. Chem. 34, 659-669.
28. Marks, T. A., Woodman, R. J., Geran, R. I., Billups, L. H., and Madison, R. M. (1977) Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Cancer Treat. Rep. 61, 1459-1470.
29. Horowitz, A. T., Barenholz, Y., and Gabizon, A. A. (1992) In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim. Biophys. Acta 1109, 203-209.
30. Miller, S. A., Dykes, D. D., and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
31. Senter, P. D., Wallace, P. M., Svensson, H. P., Vrudhula, V. M., Kerr, D. E., Hellstrom, I., and Hellstrom, K. E. (1993) Generation of cytotoxic agents by targeted enzymes. Bioconjugate Chem. 4, 3-9.
32. Rui, Y. J., Wang, S., Low, P. S., and Thompson, D. H. (1998) Diplasmenylcholine-folate liposomes: an efficient vehicle for intracellular drug delivery. J. Am. Chem. Soc. 120, 11213-11218.
33. Qualls, M. M., and Thompson, D. H. (2001) Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: Intracellular localization and synergistic phototoxicity. Int. J. Cancer 93, 384-392.